Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Revenue (2016 - 2025)

Pediatrix Medical (MD) has disclosed Revenue for 17 consecutive years, with $493.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue fell 1.71% to $493.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 billion, a 4.92% decrease, with the full-year FY2025 number at $1.9 billion, down 4.92% from a year prior.
  • Revenue was $493.8 million for Q4 2025 at Pediatrix Medical, roughly flat from $492.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $513.8 million in Q4 2022 to a low of $446.8 million in Q1 2021.
  • A 5-year average of $490.2 million and a median of $493.4 million in 2021 define the central range for Revenue.
  • Peak YoY movement for Revenue: increased 19.66% in 2021, then decreased 7.42% in 2025.
  • Pediatrix Medical's Revenue stood at $498.5 million in 2021, then rose by 3.07% to $513.8 million in 2022, then dropped by 3.39% to $496.4 million in 2023, then increased by 1.19% to $502.4 million in 2024, then decreased by 1.71% to $493.8 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Revenue are $493.8 million (Q4 2025), $492.9 million (Q3 2025), and $468.8 million (Q2 2025).